States loosen vaccine rules — even as measles outbreak rages
With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.
With a longtime vaccine skeptic serving as the country’s top health official, the movement is likely to make further inroads.
If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.
“Science Guy” takes nominee to head HHS to task over fluoride in drinking water.
“Science Guy” takes nominee to head HHS to task over fluoride in drinking water.
“Science Guy” takes nominee to head HHS to task over fluoride in drinking water.
“Science Guy” takes nominee to head HHS to task over fluoride in drinking water.
“Science Guy” takes nominee to head HHS to task over fluoride in drinking water.
“Science Guy” takes nominee to head HHS to task over fluoride in drinking water.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.
The decision preserves the Biden administration’s power to begin haggling with drug companies over the prices of 10 medications.